M. Lenoci
Impact in
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
- Hematology top 10%
- Acute Myeloid Leukemia Research
Papers in
- Genetics 5
- Chronic Lymphocytic Leukemia Research 5
-
- Lymphoma Diagnosis and Treatment 3
- Co-authors
- Francesco Lauria (6 shared papers)Monica Tozzi (4 shared papers)Donatella Raspadori (4 shared papers)Giuseppe Marotta (4 shared papers)Monica Bocchia (4 shared papers)Damiano Rondelli (2 shared papers)Geraldo de Nardi (2 shared papers)Nicoletta Testoni (1 shared paper)
- Journals
- Leukemia (2 papers)Journal of Clinical Microbiology (1 paper)British Journal of Haematology (1 paper)Blood (1 paper)Leukemia & lymphoma (1 paper)
- Partner nations
- ItalyUnited Kingdom
In The Last Decade
M. Lenoci
8 papers receiving 293 citations
Peers
Comparison fields: 5 of 43
- Genetics 151
- Hematology 99
- Pathology and Forensic Medicine 124
- Immunology 85
- Oncology 50
Countries citing papers authored by M. Lenoci
This map shows the geographic impact of M. Lenoci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Lenoci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Lenoci more than expected).
Fields of papers citing papers by M. Lenoci
This network shows the impact of papers produced by M. Lenoci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Lenoci. The network helps show where M. Lenoci may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Lenoci, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 128 | |
| 2 | Efficacy of anti-CD20 monoclonal antibodies (Mabthera) in patients with progressed hairy cell leukemia. | 2001 | 70 |
| 3 | Low-dose fludarabine and cyclophosphamide in elderly patients with B-cell chronic lymphocytic leukemia refractory to conventional therapy. | 2000 | 43 |
| 4 | 2006 | 40 | |
| 5 | 1999 | 16 | |
| 6 | 2004 | 4 | |
| 7 | 2005 | 3 | |
| 8 | 2003 | 1 |
About M. Lenoci
M. Lenoci is a scholar working on Genetics, Pathology and Forensic Medicine, Oncology, Epidemiology and Infectious Diseases, having authored 8 papers that have together received 305 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (5 papers), Lymphoma Diagnosis and Treatment (3 papers), Acute Myeloid Leukemia Research (1 paper), Viral-associated cancers and disorders (1 paper), Multiple Myeloma Research and Treatments (1 paper), CNS Lymphoma Diagnosis and Treatment (1 paper), Antifungal resistance and susceptibility (1 paper) and Monoclonal and Polyclonal Antibodies Research (1 paper). The work is most often cited by research in Genetics (151 citations), Hematology (99 citations), Pathology and Forensic Medicine (124 citations), Immunology (85 citations) and Oncology (50 citations). M. Lenoci has collaborated with scholars based in Italy and United Kingdom. Frequent co-authors include Francesco Lauria, Monica Tozzi, Donatella Raspadori, Giuseppe Marotta, Monica Bocchia, Damiano Rondelli, Geraldo de Nardi, Nicoletta Testoni, Caterina Mariotti and Daniela Damiani. Their work appears in journals such as Leukemia, Journal of Clinical Microbiology, British Journal of Haematology, Blood and Leukemia & lymphoma.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.